RT Journal Article
SR Electronic
T1 A snap shot of space and time dynamics of COVID-19 risk in Malawi. An application of spatial temporal model
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2020.09.12.20192914
DO 10.1101/2020.09.12.20192914
A1 Alfred Ngwira
A1 Felix Kumwenda
A1 Eddons Munthali
A1 Duncan Nkolokosa
YR 2020
UL http://medrxiv.org/content/early/2020/09/14/2020.09.12.20192914.abstract
AB Background COVID-19 has been the greatest challenge the world has faced since the second world war. The aim of this study was to investigate the distribution of COVID-19 in both space and time in Malawi.Methods The study used publicly available data of COVID-19 cases for the period from 24th June to 20th August, 2020. Semiparametric spatial temporal models were fitted to the number of weekly confirmed cases as an outcome data, with time and location as independent variables.Results The study found significant main effect of location and time with the two interacting. The spatial distribution of COVID-19 showed major cities being at greater risk than rural areas. Over time the COVID-19 risk was increasing then decreasing in most districts with the rural districts being consistently at lower risk.Conclusion Future or present strategies to avert the spread of COVID-19 should target major cities by limiting international exposure. In addition, the focus should be on time points that had shown high risk.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThe study did not receive any form of funding.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:NAAll necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesData is available upon request from the corresponding author